Agios Pharmaceuticals (AGIO) Accumulated Depreciation & Amortization (2016 - 2025)
Historic Accumulated Depreciation & Amortization for Agios Pharmaceuticals (AGIO) over the last 14 years, with Q4 2025 value amounting to $60.1 million.
- Agios Pharmaceuticals' Accumulated Depreciation & Amortization rose 640.39% to $60.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $60.1 million, marking a year-over-year increase of 640.39%. This contributed to the annual value of $60.1 million for FY2025, which is 640.39% up from last year.
- Agios Pharmaceuticals' Accumulated Depreciation & Amortization amounted to $60.1 million in Q4 2025, which was up 640.39% from $56.5 million recorded in Q4 2024.
- In the past 5 years, Agios Pharmaceuticals' Accumulated Depreciation & Amortization ranged from a high of $60.1 million in Q4 2025 and a low of $45.0 million during Q4 2021
- For the 5-year period, Agios Pharmaceuticals' Accumulated Depreciation & Amortization averaged around $52.8 million, with its median value being $52.2 million (2023).
- As far as peak fluctuations go, Agios Pharmaceuticals' Accumulated Depreciation & Amortization skyrocketed by 1133.1% in 2022, and later soared by 431.2% in 2023.
- Agios Pharmaceuticals' Accumulated Depreciation & Amortization (Quarter) stood at $45.0 million in 2021, then grew by 11.33% to $50.1 million in 2022, then rose by 4.31% to $52.2 million in 2023, then increased by 8.17% to $56.5 million in 2024, then rose by 6.4% to $60.1 million in 2025.
- Its Accumulated Depreciation & Amortization was $60.1 million in Q4 2025, compared to $56.5 million in Q4 2024 and $52.2 million in Q4 2023.